<!DOCTYPE html>
<html lang="en">

<!-- defines the default zoom for mobile devices -->
<meta name="viewport" content="width=device-width, initial-scale=1" />
<head>
  <meta charset="UTF-8">
 <title>CardioRef: AHA/ACC 2015 Sports Participation Selector Guide: Aortic Diseases or Marfan Syndrome</title>

 <link rel="stylesheet" href="css/sports_answer_combined.css">

<style>
div{
    -webkit-margin-before:0;
    -webkit-margin-after:0;
    -webkit-margin-start:0;
    -webkit-margin-end:0;
}

</style>

</head>

<body>
  <div class="topbar">
    <a href="index.html">Pedi CardioRef</a>
    <div class="guidelinebar">
    <a target="_blank" rel="noopener noreferrer" href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000243">
      Reference: ACC/AHA Sports Participation Recommendations (Circulation 2015)
      Task Force 7: Aortic Diseases, Including Marfan Syndrome</a>
    </div>
  </div>

<section style="margin:10px">
  <p class="topspace"></p>

<label><b>By the ACC/AHA 2015 guidelines, should my patient with</label>
  <select name="disease" id="dz" class="InputBox" onChange="goThere();">
  <option value="">*Select Disease*</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="HCM">Hypertrophic Cardiomyopathy </option>
  <option value="LVNC">Left Ventricular Non-Compaction </option>
  <option value="DilRestr">Dilated or Restrictive Cardiomyopathy </option>
  <option value="ARVC">Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) </option>
  <option value="Myo">Myocarditis </option>
  <option value="Peri">Pericarditis </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="ASDVSDPDA">ASD, VSD, or PDA </option>
  <option value="PS">Pulmonic Stenosis </option>
  <option value="AS">Aortic Stenosis </option>
  <option value="Coarct">Coarctation </option>
  <option value="Cyan">Cyanotic Heart Disease, unrepaired or with palliative shunt </option>
  <option value="TOF">Tetralogy of Fallot, s/p repair </option>
  <option value="TGA_Must">d-transposition (d-TGA), s/p atrial switch (Mustard/Senning)</option>
  <option value="TGA_Art">d-transposition (d-TGA), s/p arterial switch </option>
  <option value="CCTGA">Congenitally-corrected TGA (CC-TGA, L-TGA)</option>
  <option value="Fontan">Fontan </option>
  <option value="Ebstein">Ebstein Anomaly </option>
  <option value="AnomCoronary">Anomalous Coronary Artery Origin</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="PVR">Elevated PVR in CHD </option>
  <option value="VentricularDysfxn">Ventricular Dysfunction s/p CHD Surgery</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Valve_AS">Aortic Stenosis</option>
  <option value="Valve_AR">Aortic Regurgitation </option>
  <option value="Valve_MS">Mitral Stenosis</option>
  <option value="Valve_MR">Mitral Regurgitation </option>
  <option value="Valve_Hx">History of Cardiac Valve Surgery</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="HTN">Hypertension </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Marfan">Aortic Diseases and Marfan Syndrome</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="CoronaryOverview">Coronary Artery Disease </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Syncope">Syncope </option>
  <option value="Arrhythmia">Arrhythmias (SVT, PVC, Vtach, etc.) </option>
  <option value="ConductionDefect">Conduction Defects (AV block, brady, pacemaker, RBBB/LBBB)</option>
  <option value="Channelopathies">Channelopathies (LQTS, CPVT, Brugada, etc.) </option>
  <option value="ICD">Implantable Cardioverter-Defibrillator (ICD) </option>
  </select>


  <span>participate in organized sports?</span></b>


<br><br>
<section id="question">
Should my patient with <b>Aortic Diseases or Marfan Syndrome</b> participate in organized sports?
</section>
  </section>
<br>
<section id="needtoknow">
  <p class="sectiontitle">Need to know:</p>
  <ul>
  <li>Syndrome or genetic abnormality?</li>
  <li>Aortic dimensions</li>
  <li>Valve function (aortic, mitral)</li>
  <li>Ventricular function</li>
  <li>History of surgical repair?</li>
  </ul>
</section>

<div class="multi">
<ul class="tabs">

  <li class="tab">
      <input type="radio" name="tabs" checked="checked" id="tab1" />
      <label for="tab1">BAV</label>
      <div id="tab-content1" class="content">
        <h1>Bicuspid Aortic Valve</h1>
        <hr>
        <section id="needtoknow">
          <p class="sectiontitle">Need to know:</p>
          <ul>
          <li>Aortic root or ascending aorta dilation</li>
          <li>Valvular function (see Task Force 5 on valvular heart disease)</li>
          <li>Any associated connective tissue disorder</li>
          <br>
          </ul>

          <p class="sectiontitle">Need to perform:</p>
          <p>"Athletes with BAV and aortic dimensions above the normal range
          (scores 2–3 or aortic diameters measuring 40–42 mm in men or 36–39 mm in women)
          should undergo echocardiographic or MRA surveillance of the aorta every 12 months,
          with more frequent imaging recommended for increasing aortic z score (Class I Recommendation; Level of Evidence C)."</p>
        </section>

        <section id="answer_arrow_section">
    <section class="quarter_invisible">&#8665;</section>
    <section class="quarter_invisible">&#8665;</section>
    <section class="quarter_invisible">&#8664;</section>
    <section class="quarter_invisible">&#8664;</section>
  </section>

        <section class="quarter_left">
        <p class="sectiontitle">No dilation</p>
        <p>"Athletes with BAV can participate in all competitive athletics
          if the aortic root and ascending aorta are not dilated
          (ie, z score < 2, or < 2 standard deviations from the mean, or < 40 mm in adults).
          The function of the BAV (whether stenotic or regurgitant) is also important in determining participation recommendations
          (see Task Force 5 on valvular heart disease) (Class I Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_ok"><b>All sports = acceptable</b> (but see Task Force 5)</div>
        <br>
        </section>

        <section class="quarter_middleleft">
        <p class="sectiontitle">Mild-moderate aortic dilation, no connective tissue disorder</p>
        <p>
        "For athletes with a BAV and a mild to moderately dilated aorta
        (score 2–3.5 or aortic root or ascending aortic diameters measuring 40–42 mm in men or 36–39 mm in women)
        and no features of associated connective tissue disorder or familial TAA syndrome,
        participation in low and moderate static and dynamic competitive sports
        with a low likelihood of significant bodily contact (classes IA, IB, IC, IIA, IIB, and IIC)
        may be considered.
        For these athletes, avoidance of intense weight training should be considered (Class IIb Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_maybe"><b>Class IA, IB, IC, IIA, IIB, IIC with low likelihood of bodily contact = may consider.</b> Also, avoid intense weight training.</div><br>
        </section>

        <section class="quarter_middleright">
        <p class="sectiontitle">Aorta 43-45mm</p>
        <p>"For athletes with a BAV and a dilated aorta measuring 43 to 45 mm,
          participation in low-intensity competitive sports (class IA)
          with a low likelihood of bodily contact may be considered (Class IIb Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_maybe"><b>Class IA with low likelihood of bodily contact = may consider.</b></div>
        <br>
        </section>

        <section class="quarter_right">
        <p class="sectiontitle">Severe aortic dilation</p>
        <p>
        "Athletes with BAV and a severely dilated aorta (score >3.5 to 4 or >43 mm in men or >40 mm in women)
        should not participate in any competitive sports that involve the potential for bodily collision
        (Class III Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_no">No sports that involve potential for bodily collision</div><br>
<hr>
        <p>
        Athletes with BAV and a markedly dilated aorta (>45 mm)
        should not participate in any competitive sports (Class III Recommendation; Level of Evidence C).
        </p>
        <div class="verdict_no">No competitive sports</div><br>
        </section>

        </section>
      </div>
  </li>

  <li class="tab">
    <input type="radio" name="tabs" id="tab2" />
    <label for="tab2">Marfan</label>
    <div id="tab-content2" class="content">
        <h1>Marfan Syndrome</h1>
        <hr>

        <section id="needtoknow">
        <p class="sectiontitle">Need to perform:</p>
        <p>"Athletes with Marfan syndrome should undergo echocardiographic (and in some instances MRA or CT)
          measurement of the aortic root dimension every 6 to 12 months, depending on aortic size (Class I Recommendation; Level of Evidence C)."
        </p>
        </section>

        <section id="answer_arrow_section">
          <section class="single_invisible">&#8659;</section>
        </section>

        <section class="single_center">
        <p class="sectiontitle">Participation criteria</p>
        <p>
        "It is reasonable for athletes with Marfan syndrome to participate in
        low and moderate static/low dynamic competitive sports
        (classes IA and IIA)
        if they do not have ≥1 of the following (Class IIa Recommendation; Level of Evidence C):
        <ul>
          <li>Aortic root dilatation (ie, z score > 2, or aortic diameter >40 mm, or >2 standard deviations
            from the mean relative to BSA in children or adolescents < 15 years old</li><br>
          <li>Moderate to severe mitral regurgitation</li><br>
          <li>Left ventricular systolic dysfunction (ejection fraction < 40%)</li><br>
          <li>Family history of aortic dissection at an aortic diameter < 50 mm"</li>
        </ul>

        </p>
        <div class="verdict_maybe"><b>Class IA and IIA = reasonable</b>, if patient has <u>none</u> of the above findings.</div><br>

        <hr>

        <p>
        "Athletes with Marfan syndrome, familial TAA syndrome, Loeys-Dietz syndrome,
        unexplained aortic aneurysm, vascular Ehlers-Danlos syndrome,
        or a related aortic aneurysm disorder should <u>not</u> participate in
        any competitive sports that involve intense physical exertion or the potential for bodily collision
        (Class III Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_no"><b>No sports involving intense physical exertion or potential for bodily collision</b></div><br>

        </section>

  </li>

  <li class="tab">
    <input type="radio" name="tabs" id="tab3" />
    <label for="tab3">TAA</label>
    <div id="tab-content3" class="content">
        <h2>Unexplained thoracic aortic aneurysm (TAA) or familial TAA syndrome</h2>
          <h3>Or known mutation leading to familial TAA syndrome (ACTA2, MYH11, FBN1, TGFBR1, TGFBR2, MLCK, SMAD3, TGFB2, and others) </h3>
        <hr>
        <section id="needtoknow">
          <p class="sectiontitle">Need to perform:</p>
          <p>"Athletes with unexplained TAA, familial TAA syndrome, or known pathogenic mutation leading to a
            familial TAA syndrome (ACTA2, MYH11, FBN1, TGFBR1, TGFBR2, MLCK, SMAD3, TGFB2, and others)
            should undergo <b>echocardiographic and (depending on the diagnosis) MRA or CT surveillance
            every 6 to 12 months</b> to evaluate for progression of aortic or branch vessel disease
            (Class I Recommendation; Level of Evidence C)."</p>
        </section>

        <section id="answer_arrow_section">
          <section class="single_invisible">&#8659;</section>
        </section>

        <section class="single_center">
        <p class="sectiontitle">Participation criteria</p>
        <p>"It is reasonable for athletes with an unexplained TAA, familial TAA syndrome,
          or known pathogenic mutation leading to familial TAA syndrome
          (ACTA2, MYH11, FBN1, TGFBR1, TGFBR2, MLCK, SMAD3, TGFB2, and others)
          to participate in low static, low dynamic competitive sports (class IA)
          <b>if they do not have ≥1 of the following</b> (Class IIa Recommendation; Level of Evidence C):
          <ul>
            <li>Aortic root dilatation (ie, score >2, or aortic diameter >40 mm,
            or >2 standard deviations from the mean relative to BSA for children and adolescents < 15 years old)</li>

            <li>Moderate to severe mitral regurgitation</li>

            <li>Family history of aortic dissection</li>

            <li>Cerebrovascular disease</li>

            <li>Branch vessel aneurysm or dissection"</li>
          </ul>
        </p>
        <div class="verdict_maybe"><b>Class IA = reasonable</b>, if patient has none of the above findings.</div>
        <br> <hr>
        <p>"Athletes with Marfan syndrome, <b>familial TAA syndrome</b>, Loeys-Dietz syndrome, unexplained aortic aneurysm,
          vascular Ehlers-Danlos syndrome, or a related aortic aneurysm disorder should
          <u>not</u> participate in any competitive sports that involve
          intense physical exertion or the potential for bodily collision (Class III Recommendation; Level of Evidence C)."</p>
          <div class="verdict_no"><b>No sports that involve intense physical exertion or potential for bodily collision.</b></div>
        <br>
        </section>

     </div>
  </li>

  <li class="tab">
    <input type="radio" name="tabs" id="tab4" />
    <label for="tab4">Loeys-Dietz | Ehlers-Danlos</label>
    <div id="tab-content4" class="content">
        <h1>Loeys-Dietz or vascular Ehlers-Danlos</h1>
        <hr>
        <section class="single_center">
          <p class="sectiontitle">Participation Criteria:</p>
          <p>"It is reasonable for athletes with Loeys-Dietz syndrome or vascular Ehlers-Danlos syndrome
            to participate in low static, low dynamic sports (class IA)
            <b>if they do <u>not</u> have any of the following</b> (Class IIa Recommendation; Level of Evidence C):
            <ul>
            <li>Aortic enlargement (score >2) or dissection, or branch vessel enlargement</li>
            <li>Moderate to severe mitral regurgitation</li>
            <li>Extracardiac organ system involvement that makes participation hazardous"</li>
            </ul>
          </p>
          <div class="verdict_maybe"><b>Class IA sports = reasonable</b>, if patient has none of the above findings.</div><br>
          <hr>
          <p>"Athletes with Marfan syndrome, familial TAA syndrome, <b>Loeys-Dietz syndrome</b>, unexplained aortic aneurysm,
            <b>vascular Ehlers-Danlos syndrome</b>, or a related aortic aneurysm disorder should
            <u>not</u> participate in any competitive sports that involve
            intense physical exertion or the potential for bodily collision (Class III Recommendation; Level of Evidence C)."</p>
            <div class="verdict_no"><b>No sports that involve intense physical exertion or potential for bodily collision.</b></div>
          <br>
        </section>

     </div>
  </li>

  <li class="tab">
    <input type="radio" name="tabs" id="tab5" />
    <label for="tab5">Non-syndrome/-familial</label>
    <div id="tab-content5" class="content">
        <h1>Aortic dimensions above the normal range*
        <br>& no features of Marfan syndrome, Loeys-Dietz, or familial TAA syndrome </h1>
        <h3>(*z scores >2, or aortic root diameters measuring >40mm in tall men or >35mm in tall women)</h3>

        <hr>
        <section id="needtoknow">
          <p class="sectiontitle">Need to perform:</p>
          <p>"Athletes with aortic dimensions mildly above the normal range
            (z scores 2–2.5 or aortic root diameters measuring 40–41 mm in tall men or 36–38 mm in tall women)
            and no features of Marfan syndrome, Loeys-Dietz syndrome, or familial TAA syndrome
            should undergo <b>echocardiographic or MRA surveillance every 6 to 12 months</b>,
            with imaging frequency dependent on aortic size and stability of measurements (Class I Recommendation; Level of Evidence C)."</p>
        </section>

        <section id="answer_arrow_section">
          <section class="single_invisible">&#8659;</section>
        </section>

        <section class="single_center">
        <p class="sectiontitle">Participation Criteria:</p>
        <p>"For athletes with aortic dimensions mildly above the normal range
          (scores 2–2.5 or aortic root diameters measuring 40–41 mm in tall men or 35–37 mm in tall women)
          and <u>no</u> features of Marfan syndrome, Loeys-Dietz syndrome, familial TAA syndrome, or BAV,
          <b>participation in all competitive athletics may be considered
          after a comprehensive evaluation for an underlying genetic condition associated with aortopathy is performed.</b>
        </p><p>This may include analysis for mutations in FBN1 and other genes associated with aortopathies in certain circumstances
          (Class IIb Recommendation; Level of Evidence C)."
        </p>
        <div class="verdict_maybe"><b>Can consider all sports</b>, after comprehensive evaluation for genetic condition is performed.</div> <br>
        <hr>
        <p>"For athletes with aortic dimensions mildly above the normal range
          (scores 2–2.5 or aortic root diameters measuring 40–41 mm in tall men or 35–37 mm in tall women)
          and <u>no</u> features of Marfan syndrome, Loeys-Dietz syndrome, familial TAA syndrome,
          or BAV, avoidance of intense weight training may be considered (Class IIb Recommendation; Level of Evidence C)."</p>
        <div class="verdict_maybe"><b>Can consider avoidance of intense weight training</b></div>
        <br>
        </section>
     </div>
  </li>


  <li class="tab">
    <input type="radio" name="tabs" id="tab6" />
    <label for="tab6">S/p surgery</label>
    <div id="tab-content6" class="content">
        <h1>S/p surgical correction and no residual aortic enlargement/dissection</h1>
        <hr>
        <section class="single_center">
          <p class="sectiontitle">If no residual enlargement or dissection:</p>
          <p>"It is reasonable for athletes with surgical correction of the aortic root or ascending aorta
            for aneurysm disease or dissection and
            <u>no</u> evidence of residual aortic enlargement or dissection to participate in low static, low dynamic sports (class IA)
            that do not include the potential for bodily collision (Class IIa Recommendation; Level of evidence C)."</p>
          <div class="verdict_maybe"><b>Class IA sports without the potential for bodily collision = Reasonable</b>, if no residual enlargement/dissection</div>
          <br>
        </section>

     </div>
  </li>

    <li class="tab">
      <input type="radio" name="tabs" id="tab7" />
      <label for="tab7">Aneurysm or dissection</label>
      <div id="tab-content7" class="content">
          <h1>Chronic aortic dissection or branch vessel aneurysm/dissection</h1>
          <hr>
          <section class="single_center">
            <p class="sectiontitle"></p>
            <p>"Athletes with chronic aortic dissection or branch vessel arterial aneurysm or dissection
              should not participate in any competitive sports (Class III Recommendation; Level of Evidence C)."</p>
          <div class="verdict_no"><b>No competitive sports</b></div>
          <br>
          </section>
       </div>
    </li>

</ul>
</div>

<p class="foot">
  <br><br><br><br><br><br><br><br><br><br>  <br><br><br><br><br><br><br><br><br><br>  <br><br><br><br><br><br><br><br><br><br>
  <b>Reference:</b> <a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000243"><i>Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome.
    A Scientific Statement From the AHA and ACC.</i></a> <i>Circulation 2015</i>
  <br><br><b>Disclaimer:</b> This website is derived from published guidelines, but does not constitute medical advice nor does it replace clinical judgement. Only the text in quotation marks are direct quotations from the original guidelines. Text not in quotations as well as the method of information display are all that of the website creator and are not part of the original published guidelines. Please consult a physician to discuss any patient-specific matters.
</p>


<section class="key">
<p><b>Key:</b>BAV = bicuspid aortic valve, TAA = thoracic aortic aneurysm
</p>
</section>


<script>

function goThere(){
  var disease = document.getElementById("dz").value;
  location.href= disease+'_Overview.html';
}

function getState() {
    var disease = document.getElementById("dz").value;
    var sport = document.getElementById("spt").value;
    if(disease && sport) {
      console.log(disease);
      console.log(sport);
      console.log(disease+sport);
      combo=disease+sport;
location.href = combo+'.html';

    }
}
function toggle_table() {
  var x = document.getElementById("elaboration");
  if (x.style.display === "block") {
    x.style.display = "none";
  } else {
    x.style.display = "block";
  }
}

  </script>

</html>
